Status:
COMPLETED
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
Lead Sponsor:
Azienda Ospedaliero Universitaria di Cagliari
Conditions:
Psychiatric Disorders
Cognitive Impairment
Eligibility:
All Genders
18+ years
Brief Summary
Chronic hepatitis HCV-related is the most common cause of chronic liver disease in Italy. Patients with chronic hepatitis C present a prevalence of depressive disorders higher than that of the general...
Detailed Description
Background HCV-related chronic hepatitis represents the most common cause of chronic liver disease in Italy, with an estimated prevalence of 1-1.1% in the general population, reaching about 15% in sub...
Eligibility Criteria
Inclusion
- diagnosis of chronic hepatitis HCV-related, eligible to new antiviral drugs treatments
- understanding Italian language
- signed informed consent
Exclusion
- severe cognitive deficits
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03313154
Start Date
November 1 2015
End Date
September 1 2018
Last Update
January 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Universitario di Monserrato
Monserrato, Cagliari, Italy, 09042